Neurology Specific Literature Search   
 
[home][thesaurus]
    
Click Here to return To Results

 

Acute demyelinating polyneuropathy induced by nivolumab
JNNP 89:435-437, Fukumoto, Y.,et al, 2018
See this aricle in Pubmed

Article Abstract
Nivolumab has emerged as an effective treatment for advanced cancers such as melanoma and non-small cell lung cancer (NSCLC). However, immune-related adverse events (irAEs) are sometimes associated with the administration of immune checkpoint inhibitors. Colitis, endocrine dysfunction and myasthenia gravis (MG) are well-known irAEs irAEs induced by nivolumab. Here, we report a case of nivolumab-induced acute demyelinating polyneuropathy.
 
Related Tags
(click to filter results - removes previous filter)

adverse drug reaction
carcinoma
carcinoma of lung
complications
Guillain Barre syndrome
immune checkpoint inhibitors
immune-related adverse events
monoclonal antibodies
myasthenia gravis
myasthenia gravis,drug induced
nivolumab
pembrolizumab
treatment of neurologic disorder

Click Here to return To Results